Bharat Immunological & Biological Corporation Ltd: Financial Statements & Historical Data

Bharat Immunological & Biological Corporation Ltd: The quarter ending Sep 2023 recorded a net loss of ₹4.92 crore; the loss widened from ₹3.08 crore in Sep 2022. Sales fell 100.0% to ₹0.00 crore against Sep 2022. The full year ending Mar 2023 recorded a net loss of ₹17 crore. The latest stored performance period is more than seven months old; check for newer filings.

Calculated from the stored statements below · Reporting periods remain separate

COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 8 October 2026, 5:43 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price8.84₹ per share

Reported P/ENot availableTimes

Book value per share18.2₹ per share

Reported ROCE9.27 %Reported return

Stored market and accounting figures

Price record: 8 October 2026, 5:43 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	38.2 Cr.
Current Price	8.84
High / Low	22.6/7.11
Stock P/E	Not available
Book Value	18.2
Dividend Yield	0.00 %
ROCE	9.27 %
ROE	17.7 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Sep 2023

The quarter ending Sep 2023 recorded a net loss of ₹4.92 crore; the loss widened from ₹3.08 crore in Sep 2022. Sales fell 100.0% to ₹0.00 crore against Sep 2022. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
Sales	25.36	25.20	15.62	14.22	24.70	17.43	22.04	10.48	26.48	0.00	7.65	0.00	0.00
Expenses	29.86	27.47	31.54	13.18	28.19	16.41	25.71	15.31	28.98	4.72	11.67	4.31	4.68
Operating Profit	-4.50	-2.27	-15.92	1.04	-3.49	1.02	-3.67	-4.83	-2.50	-4.72	-4.02	-4.31	-4.68
OPM %	-17.74%	-9.01%	-101.92%	7.31%	-14.13%	5.85%	-16.65%	-46.09%	-9.44%		-52.55%
Other Income	0.14	1.20	9.08	0.25	0.22	0.12	0.59	0.14	0.32	0.10	0.49	0.10	0.16
Interest	1.17	1.30	1.22	1.16	1.23	1.54	1.68	1.58	1.74	1.67	2.06	1.72	2.09
Depreciation	0.06	0.06	0.06	0.06	0.06	0.04	0.05	0.04	0.04	0.04	0.09	0.03	0.03
Profit before tax	-5.59	-2.43	-8.12	0.07	-4.56	-0.44	-4.81	-6.31	-3.96	-6.33	-5.68	-5.96	-6.64
Tax %	-30.77%	-21.81%	-19.46%	-2,642.86%	105.26%	-25.00%	-11.02%	-20.76%	-22.22%	-26.07%	-31.69%	-23.15%	-26.05%
Net Profit	-3.87	-1.89	-6.53	1.93	-9.36	-0.33	-4.28	-5.00	-3.08	-4.68	-3.88	-4.59	-4.92
EPS in Rs	-0.90	-0.44	-1.51	0.45	-2.17	-0.08	-0.99	-1.16	-0.71	-1.08	-0.90	-1.06	-1.14

Last Updated: September 30, 2026, 10:09 pm

EARNINGS

Annual performance

Mar 2023

The year ending Mar 2023 recorded a net loss of ₹17 crore; the loss widened from ₹9.00 crore in Mar 2022. Sales fell 42.3% to ₹45 crore against Mar 2022. Operating margin fell from -6.4% to -40.0% (33.6 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 30, 2026, 10:09 pm

Metric	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	46	173	203	146	128	124	35	84	67	85	78	45	8
Expenses	41	164	191	143	132	111	43	93	77	106	83	63	25
Operating Profit	6	9	12	3	-4	13	-8	-9	-10	-21	-5	-18	-18
OPM %	12%	5%	6%	2.3%	-3.1%	10%	-23%	-11%	-16%	-24%	-6%	-41%	-232%
Other Income	2	1	6	1	1	1	1	4	1	2	1	3	1
Interest	0	2	6	1	6	4	1	2	5	5	6	7	8
Depreciation	1	1	1	1	1	1	0	0	0	0	0	0	0
Profit before tax	6	7	11	2	-9	9	-8	-7	-14	-24	-10	-23	-25
Tax %	-111%	27%	42%	26%	-31%	29%	-46%	-21%	-28%	-25%	-10%	-25%
Net Profit	13	5	6	2	-6	7	-4	-6	-10	-18	-9	-17	-18
EPS in Rs	2.91	1.16	1.48	0.36	-1.44	1.51	-0.99	-1.34	-2.36	-4.19	-2.03	-3.95	-4.18
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Year-on-year profit growth table

YoY Net Profit Growth

Year	2012-2013	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023
YoY Net Profit Growth (%)	-61.54%	20.00%	-66.67%	-400.00%	216.67%	-157.14%	-50.00%	-66.67%	-80.00%	50.00%	-88.89%
Change in YoY Net Profit Growth (%)	0.00%	81.54%	-86.67%	-333.33%	616.67%	-373.81%	107.14%	-16.67%	-13.33%	130.00%	-138.89%

Growth

Compounded Sales Growth
10 Years:	-13%
5 Years:	5%
3 Years:	-13%
TTM:	-90%

Compounded Profit Growth
10 Years:	Not available
5 Years:	Not available
3 Years:	-31%
TTM:	-42%

Stock Price CAGR
10 Years:	-1%
5 Years:	-10%
3 Years:	-9%
1 Year:	-24%

Return on Equity
10 Years:	-12%
5 Years:	-24%
3 Years:	-23%
Last Year:	-18%

Last Updated: September 5, 2025, 2:41 pm

CASH & FUNDING

Balance sheet

Sep 2023

Reported borrowings stood at ₹74 crore in Sep 2023. Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 30, 2026, 10:09 pm

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	43	43	43	43	43	43	43	43	43	43	43	43	43
Reserves	-15	-1	-3	-2	-8	-1	-6	-12	-23	-9	62	45	36
Borrowings	7	0	-1	-9	9	0	0	32	3	27	78	70	74
Other Liabilities	45	48	52	48	24	17	16	62	103	43	29	28	35
Total Liabilities	81	90	91	80	68	59	53	125	127	104	213	186	188
Fixed Assets	9	8	7	6	6	5	5	5	4	4	116	115	115
CWIP	1	0	0	0	0	0	0	0	0	32	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	71	82	84	74	63	53	48	120	122	68	97	70	73
Total Assets	81	90	91	80	68	59	53	125	127	104	213	186	188

CASH & FUNDING

Cash generation

Mar 2023

Operating activities generated ₹11 crore in Mar 2023. Reported free cash flow for the same period was ₹11 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	5	31	-12	8	-9	-17	3	-32	34	12	-42	11
Cash from Investing Activity +	-0	0	0	0	1	0	-1	1	1	1	1	0
Cash from Financing Activity +	-3	-0	-6	-1	-2	-3	-1	31	-34	-12	45	-15
Net Cash Flow	2	31	-18	7	-10	-20	1	-1	1	0	3	-3
Free Cash Flow	5	32	-12	8	-9	-17	3	-32	34	12	-42	11
CFO/OP	89%	338%	-99%	229%	239%	-132%	-32%	344%	-328%	-56%	847%	-59%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Free Cash Flow	5.00	32.00	-12.00	8.00	-9.00	-17.00	3.00	-32.00	34.00	12.00	-42.00	11.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2023

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were -549 in Mar 2023. That is 322 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	209	2	47	34	37	19	167	318	96	0	5	114
Inventory Days	241	87	66	84	77	2	23	67	308	56	202	13
Days Payable	316	99	70	103	26	1	6	204	259	61	5	4
Cash Conversion Cycle	134	-9	43	16	88	19	185	181	145	-5	203	122
Working Capital Days	-20	-20	21	20	28	-19	59	10	-108	-174	-227	-549
ROCE %	20%	23%	42%	9%	-8%	31%	-18%	-11%	-22%	-46%	-3%	-9%

SHAREHOLDERS

Ownership trends

Mar 2024

Promoters held 59.25% in Mar 2024. Their share was unchanged from Mar 2023. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction.

Shareholding comparison

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoters	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%	59.25%
Public	40.75%	40.75%	40.75%	40.75%	40.75%	40.75%	40.75%	40.74%	40.74%	40.75%	40.75%	40.74%
No. of Shareholders	38,195	36,799	36,869	36,323	35,695	35,442	36,242	35,550	34,818	34,201	34,910	35,313

This stock is not held by any mutual fund.

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-3.95	-2.03	-4.19	-2.36	-1.57
Diluted EPS (Rs.)	-3.95	-2.03	-4.19	-2.36	-1.57
Cash EPS (Rs.)	-3.92	-1.98	-4.14	-2.31	-1.28
Book Value[Excl.RevalReserv]/Share (Rs.)	20.33	24.40	7.88	4.74	7.10
Book Value[Incl.RevalReserv]/Share (Rs.)	20.33	24.40	7.88	4.74	7.10
Revenue From Operations / Share (Rs.)	10.33	18.15	19.76	15.48	19.37
PBDIT / Share (Rs.)	-3.63	-0.89	-4.45	-2.14	-1.18
PBIT / Share (Rs.)	-3.66	-0.94	-4.50	-2.19	-1.24
PBT / Share (Rs.)	-5.29	-2.24	-5.61	-3.29	-1.71
Net Profit / Share (Rs.)	-3.95	-2.03	-4.19	-2.36	-1.34
PBDIT Margin (%)	-35.11	-4.95	-22.49	-13.80	-6.08
PBIT Margin (%)	-35.44	-5.22	-22.76	-14.15	-6.41
PBT Margin (%)	-51.22	-12.35	-28.36	-21.25	-8.81
Net Profit Margin (%)	-38.23	-11.16	-21.22	-15.27	-6.92
Return on Networth / Equity (%)	-19.42	-8.30	-53.20	-49.87	-18.88
Return on Capital Employeed (%)	-16.78	-3.67	-48.70	-36.22	-14.71
Return On Assets (%)	-9.18	-4.11	-17.41	-8.05	-4.63
Total Debt / Equity (X)	0.79	0.73	0.80	0.14	1.05
Asset Turnover Ratio (%)	0.22	0.49	0.73	0.53	0.93
Current Ratio (X)	0.36	0.64	0.52	0.92	1.12
Quick Ratio (X)	0.34	0.28	0.31	0.41	0.95
Inventory Turnover Ratio (X)	1.75	2.38	1.87	2.08	10.43
Interest Coverage Ratio (X)	-2.22	-0.69	-4.02	-1.95	-2.54
Interest Coverage Ratio (Post Tax) (X)	-1.42	-0.56	-2.79	-1.15	-1.89
Enterprise Value (Cr.)	157.30	186.21	213.23	16.07	57.50
EV / Net Operating Revenue (X)	3.53	2.38	2.50	0.24	0.68
EV / EBITDA (X)	-10.04	-47.96	-11.11	-1.74	-11.29
MarketCap / Net Operating Revenue (X)	2.15	1.55	2.30	0.37	0.39
Price / BV (X)	1.09	1.15	5.77	1.23	1.08
Price / Net Operating Revenue (X)	2.15	1.55	2.30	0.37	0.39
EarningsYield	-0.17	-0.07	-0.09	-0.40	-0.17

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Bharat Immunological & Biological Corporation Ltd	38.2 Cr.	8.84	22.6/7.11		18.2	0.00 %	9.27 %	17.7 %	10.0
Murae Organisor Ltd	38.8 Cr.	0.19	0.44/0.19	2.56	1.02	0.00 %	4.20 %	5.69 %	1.00
Bacil Pharma Ltd	34.8 Cr.	24.2	61.8/10.6	53.5	17.3	0.00 %	3.93 %	6.21 %	10.0
Chandra Bhagat Pharma Ltd	28.8 Cr.	38.2	53.0/29.7	9.45	43.9	0.00 %	12.1 %	9.67 %	10.0
ANG Lifesciences India Ltd	48.4 Cr.	37.1	49.7/17.6		47.6	0.00 %	1.14 %	7.38 %	10.0
Industry Average	17,127.26 Cr	1,216.62		53.25	211.24	0.40%	26.16%	16.59%	6.06

All Competitor Stocks of Bharat Immunological & Biological Corporation Ltd